|HPV Vaccine Does Not Cause Multiple Sclerosis|
Respiratory, thoracic and mediastinal disorders: Pulmonary embolus. Gastrointestinal disorders: ... Immune system disorders: Autoimmune diseases, hypersensitivity reactions including anaphylactic/anaphylactoid reactions, bronchospasm, and urticaria.
Science 2.0 - Mon, 20 Oct 2014 15:02
|Baxter Launches HYQVIA in the United States for Adult Patients with Primary ...|
Severe hypersensitivity reactions may occur, even in patients who have tolerated previous treatment with IgG. Patients with antibodies to IgA are potentially at greater risk of developing potentially severe hypersensitivity and anaphylactic reactions ...
DigitalJournal.com - Mon, 20 Oct 2014 06:07
|Experts Link Dairy Products to Surge in Infant Asthma Cases|
According to the Health Science Spirit website, asthma is medically defined as a chronic obstructive pulmonary disease, characterised by a hypersensitivity of the airways. Common symptoms of asthma include difficulty breathing with wheezing and ...
AllAfrica.com - Fri, 17 Oct 2014 16:37
|Data Published on Anoro(R) Ellipta(R) Demonstrate Improved Lung Function ...|
Theravance, Inc. (NASDAQ: THRX) -- Respiratory Medicine has published positive results from a third lung function study comparing the efficacy and safety of Anoro® Ellipta® (umeclidinium /vilanterol, 'UMEC/VI'), the combination long-acting muscarinic ...
CNNMoney - Fri, 17 Oct 2014 02:00
|FDA Approves Abuse Deterrent Labeling for EMBEDA® (morphine sulfate and ...|
EMBEDA is contraindicated in patients with significant respiratory depression, acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment, known or suspected paralytic ileus, or hypersensitivity (e.g ...
Rock Hill Herald (press release) - Fri, 17 Oct 2014 13:37
|New COPD Maintenance Treatment Striverdi® Respimat® (olodaterol ...|
We're proud to build upon our respiratory heritage by bringing STRIVERDI RESPIMAT to market as a new COPD maintenance treatment option," said Kathleen M. Dowd , senior vice president, Marketing, Boehringer Ingelheim Pharmaceuticals, Inc. "Approximately ...
Insurance News Net - Wed, 08 Oct 2014 05:00
|FDA Grants Durata Therapeutics a Special Protocol Agreement (SPA) for Its ...|
"If successful, DALVANCE would provide a single-dose treatment alternative for patients with community acquired pneumonia effective against the most common bacterial respiratory pathogens, including those resistant to other classes of antibiotics ...
GlobeNewswire (press release) - Fri, 03 Oct 2014 05:00
|Zogenix Submits Modified Formulation of Zohydro(R) ER With Potential Abuse ...|
Zohydro ER is contraindicated in patients with: significant respiratory depression; acute or severe bronchial asthma; known or suspected paralytic ileus; and hypersensitivity to hydrocodone bitartrate. Zohydro ER warnings for: interactions with CNS ...
CNNMoney - Wed, 01 Oct 2014 05:22